AOXING PHARMACEUTICAL COMPANY, INC. Shareholders' Equity
AOXING PHARMACEUTICAL COMPANY, INC. had Shareholders' Equity of $19.11 million as of 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2017-05-15
- 2017-03-31: Stockholders' Equity Attributable to Parent $19.11M.
- 2016-12-31: Stockholders' Equity Attributable to Parent $18.84M.
- 2016-09-30: Stockholders' Equity Attributable to Parent $19.53M.
- 2016-06-30: Stockholders' Equity Attributable to Parent $19.14M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2017-03-31 | $19.11M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $18.84M 10-Q · filed 2017-02-17 | |
| 2016-09-30 | $19.53M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $19.14M 10-Q · filed 2017-05-15 | |
| 2016-03-31 | $21.52M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $18.77M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $14.74M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $11.24M 10-K · filed 2016-10-05 | |
| 2015-03-31 | $5.50M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $3.90M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $2.13M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$2.51M 10-K · filed 2015-10-13 | |
| 2014-03-31 | -$172.82K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $1.65M 10-Q · filed 2014-02-19 | |
| 2013-09-30 | $3.46M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $5.67M 10-K · filed 2014-09-29 | |
| 2013-03-31 | $16.26M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $18.80M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $21.50M 10-Q/A · filed 2013-02-08 | |
| 2012-06-30 | $21.88M 10-K · filed 2013-10-15 | |
| 2012-03-31 | $35.72M 10-Q/A · filed 2012-10-01 | |
| 2011-12-31 | $35.97M 10-Q/A · filed 2012-09-28 | $38.57M 10-Q · filed 2012-02-14 |
| 2011-09-30 | $35.80M 10-Q/A · filed 2012-09-28 | $38.93M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $36.31M 10-K · filed 2012-10-15 | $38.79M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $34.31M 10-K · filed 2012-10-15 |